General Information of This Metabolic Reaction (MR) (ID:
MR006862) |
Formula |
|
Reactant |
Empagliflozin |
Product |
Empagliflozin-2-glucuronide |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
UDP-glucuronosyltransferase 1A3 (UGT1A3)
|
DME Info
|
UDP-glucuronosyltransferase 1A8 (UGT1A8)
|
DME Info
|
UDP-glucuronosyltransferase 1A9 (UGT1A9)
|
DME Info
|
UDP-glucuronosyltransferase 2B7 (UGT2B7)
|
DME Info
|
Metabolic Type
|
Conjugation
-
O-glucuronidation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
References |
1 |
Pharmacokinetics, Pharmacodynamics and Clinical Use of SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.